AzTrials
AzTrials

Nosocomial Infection in Neonatal Intensive Care UnitNCT06891768

Bacteriological Profile and Antibiotic Sensitivity in Neonatal Intensive Care Unit at Assuit University Children Hospital

An observational study of Nosocomial Infection in Neonatal Intensive Care Unit, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The study aims to assess the bacteriological profile and antibiotic sensitivity in NICU of pediatric hospital of assuit university. Read more about this study

Who is it for?
Ages 2 to 28 days
What is being tested?
Blood culture
How many people
134 participants
Where
No sites listed yet
Study dates
May 2025to Jun 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 2 to 28 days
  • All sexes
  • No healthy volunteers
  • Child

Study population: Neonates that suspected to have nosocomial infection in neonatal intensive care unit at Assuit University Children hospital

Who may be able to join

  • Neonates <28 days of life .
  • Hospital stay >48 h .
  • Neonates without signs of sepsis at time of admission .
  • Accepted to participate in this study .

Who cannot join

  • Neonates >28 days of life .
  • Hospital stay <48 h .
  • Neonates with neonatal sepsis at time of admission.
  • Refused to participate in this study .

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Madleen Thabet Hofni contact

01274437087

madlithabet@yahoo.com

About this study

The study aims to assess the bacteriological profile and antibiotic sensitivity in NICU of pediatric hospital of assuit university.

Read the detailed description

The World Health Organization (WHO) defines nosocomial infections (NI), also referred to as healthcare-associated infections (HAI's), as illnesses that develop in a patient while they are receiving treatment in a hospital or other healthcare institution but were neither present nor incubating at the time of admission . The symptoms should appear at least 2 calendar days admission to the hospital . The severity of the illness, prematurity, congenital defects, systemic diseases, degree of invasive monitoring, indiscriminate use of antibiotics, failures in sterilisation and disinfection techniques, and the type of diagnostic procedures all directly increase the risk of nosocomial infection in neonates . Long hospital stays, permanent incapacity, heightened antibiotic resistance in microorganisms, significant additional expenses for health systems, high costs for patients and their families, and avoidable deaths are all consequences of nosocomial infections . The most commonly encountered HAI's are central line associated blood stream infection (CLABSI), ventilator associated pneumonia (VAP), catheter associated urinary tract infection (CAUTI) and surgical site infections (SSI's). The other possible HAI's include meningitis, conjunctivitis and skin infections . The symptoms of health-associated infections are typically nonspecific and resemble those of other frequent neonatal diseases, including metabolic, respiratory, and thermoregulatory problems.However, improving an infant's prognosis requires prompt care. Typically, antimicrobial treatment is started without laboratory verification . Annually, more than a million neonatal deaths occur globally, with 30%-40% of these fatalities in low-resource nations linked to infections acquired in hospitals. In the NICU, bacteria, fungi, and viruses can persist and contaminate surfaces, equipment, and the surrounding environment for different lengths of time . In assuit university there is a study that has done about the incidence and risk factors of health care associated infections in NICU and it stated that out of 150 neonates , 107 developed nosocomial infection ,As regards the microbial profile and the distribution of isolated microorganisms from positive blood cultures, the most common pathogens were Staphylococcus aureus (22.7%) .The most common isolated microorganisms from positive endotracheal aspirate cultures were Klebsiella spp. (16%) . A study from Cairo university included 153 cases of neonatal sepsis; 63 (41.2%) EOS and 90 (58.8%) LOS. The majority of the neonates had very low or moderately low birth weight (90.9%). All neonates received first-line antibiotics in the form of ampicillin-sulbactam, and gentamicin. Second-line antibiotics were administered to 133 neonates (86.9%) as vancomycin and imipenem-cilastatin. Mortalities were more common among EOS group (p < 0.017). Positive blood cultures were detected in 61 neonates (39.8%) with a total number of 66 cultures. The most commonly encountered organisms were Klebsiella MDR and CoNS (31.8% each). Klebsiella MDR was the most predominant organism in EOS (28.9%), while CoNS was the most predominant in LOS (39.2%) The detected organisms were divided into 3 families; Enterobacteriaceae, non-fermenters, and Gram-positive family. There 3 families were 100% resistant to ampicillin. The highest sensitivity in Enterobacteriaceae and Non-fermenters was for colistin and polymyxin-B. An HSS of 3-8 had a sensitivity and specificity of 62.3% and 57.6%, respectively for diagnosis of culture-proven sepsis . A study from Ain Shams university included a 1-year records of a total of 1280 pathogens were studied. The highest number of pathogens were isolated from blood cultures (44.84%), followed by urine (41.41%) then wound swabs (13.75%). Gram-negative isolates (57.5%) were more prevalent than gram-positive ones (31.1%). The most frequently isolated pathogens were Klebsiella spp. (22.5%), Escherichia coli (13.4%), and Coagulase-negative Staphylococci (12.5%). The highest percentage of resistance among gram-positive organisms was exhibited by penicillin (89.5%) followed by erythromycin (83.98%) and then cefoxitin (76.52%). None of the isolates showed resistance to linezolid and resistance to vancomycin was minimal (2.62%). Gram-negative isolates exhibited high overall resistance to all used antibiotic classes. The least frequency of resistance was recorded against nitrofurantoin (52.5%), amikacin (58.01%), followed by imipenem (59.78%) and meropenem (61.82%). All isolates of Pseudomonas and Acinetobacter showed 100% susceptibility to colistin . Therefore, this study was done to know the bacteriological profile and the culture sensitivity of nosocomial infection in neonatal intensive care unit in pediatric hospital of assuit university.

Being tested
Blood culture

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood cultureDiagnostic test

    Blood culture for bacteriological profile and antibiotic sensitivity

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Bacteriological profile and antibiotic sensitivity of the nosocomial infection in neonatal intensive care unit at Assuit University Children hospital

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Mar 2025
  2. Study startMay 2025 (estimated)
  3. Primary completionMay 2026 (estimated)
  4. Study completionJun 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
134 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06891768
Sponsor's protocol ID
Ab sensitivity in neonates
Status last verified
Mar 2025
First submitted
18 Mar 2025
Last updated
25 Mar 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • 6. Salem GA. Bacterial contamination in neonatal intensive care units in Misurata, Libya: analysis of causative organisms, biofilm formation, and antimicrobial susceptibility. European Journal of Microbiology and Infectious Diseases. 2024;1(2):66-

  • Silva ACBE, Anchieta LM, Rosado V, Ferreira J, Clemente WT, Coelho JS, Mourao PHO, Romanelli RMC. Antimicrobial use for treatment of healthcare-associated infections and bacterial resistance in a reference neonatal unit. J Pediatr (Rio J). 2021 May-Jun;97(3):329-334. doi: 10.1016/j.jped.2020.06.001. Epub 2020 Jun 24.

    PubMed 32592659
  • 4. Koech CC, Rono SJ, Ngeiywa MM, Jeruto P. Neonatal Factors Predisposing Neonates to Nosocomial Infections at Moi Teaching and Referral Hospital. International Journal of Education, Science and Social Sciences. 2024;3(2):35-43.

  • 3. Shwetabh R, Upadhyay MR, Upadhyay R. Aetiological Agents in Neonatal Nosocomial Sepsis and their Sensitivity Pattern from a Tertiary Care Hospital, Odisha, India: A Crosssectional Study. Seizure. 2022;6:6.

  • 2. Moses SS, Kuruvilla TS, Praveen B. Clinicomicrobiological profile of healthcare associated infections in a neonatal intensive care unit and its relation with environmental surveillance. Panacea Journal of Medical Sciences. 2023;13(1):36-41 .

  • 1. Hogeveen M, Heijting I, Jansen S, de Boode W, Hopman J, Overbeek MGD, et al. Nosocomial infections in neonatal care: a scoping review protocol of published surveillance case definitions. 2021.

  • Fahim NAE. Prevalence and antimicrobial susceptibility profile of multidrug-resistant bacteria among intensive care units patients at Ain Shams University Hospitals in Egypt-a retrospective study. J Egypt Public Health Assoc. 2021 Mar 29;96(1):7. doi: 10.1186/s42506-020-00065-8.

    PubMed 33779849
  • 7. Mahmoud Mohammed GSED, Shoriet AH, Abdel-Aziz SM. Incidence and risk factors of health-care-associated infection in the neonatal intensive care unit of Assiut University Children's Hospital. Journal of Current Medical Research and Practice. 2021;6(1):48-53.

Questions about this trial

What is this clinical trial studying?

An observational study of Nosocomial Infection in Neonatal Intensive Care Unit, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 25 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Madleen Thabet Hofni (01274437087, madlithabet@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Bacteriological profile and antibiotic sensitivity of the nosocomial infection in neonatal intensive care unit at Assuit University Children hospital (time frame: Baseline). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06891768, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 25 Mar 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in